Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8017114 Human CTLA-4 antibodies and their uses

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Nils Lonberg0

Alan J. Korman0

Edward L. Halk0

Tibor P. Keler0

Yashwant M. Deo0

Date of Patent

September 13, 2011

0

Patent Application Number

125647560

Date Filed

September 22, 2009

0

Patent Citations Received

US Patent 12076375 Treating and preventing

0

US Patent 11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4

0

US Patent 12091681 Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy

0

US Patent 11788085 Treating and preventing microbial infections

US Patent 11779619 Oncolytic virus for expression of immune checkpoint modulators

US Patent 12090183 Methods of treating solid or lymphatic tumors by combination therapy

0

US Patent 12128018 Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immunotherapy agent for the treatment of cancer

0

Patent Primary Examiner

0

Patent abstract

The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8017114 Human CTLA-4 antibodies and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool